Patent details
EP2804863
Title:
NEW FORMS AND SALTS OF A DIHYDROPYRROLOÖ1,2-CÜIMIDAZOLYL ALDOSTERONE SYNTHASE OR AROMATASE INHIBITOR
Basic Information
- Publication number:
- EP2804863
- PCT Application Number:
- PCT/US/2013/021521
- Type:
- European Patent Granted for LU
- Legal Status:
- Lapsed
- Application number:
- EP137011946
- PCT Publication Number:
- WO/2013/109514
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- NEW FORMS AND SALTS OF A DIHYDROPYRROLOÖ1,2-CÜIMIDAZOLYL ALDOSTERONE SYNTHASE OR AROMATASE INHIBITOR
- French Title of Invention:
- NOUVELLES FORMES ET SELS D'UN INHIBITEUR DE L'ALDOSTÉRONE SYNTHASE IMIDAZOLE DIHYDROPYRROLO Ö1,2-CÜOU OU DE L'INHIBITEUR DE L'AROMATASE
- German Title of Invention:
- NEUE FORMEN UND SALZE EINES DIHYDROPYRROL-Ö1,2-C-ÜIMIDAZOLYL-ALDOSTERON-SYNTHASE- ODER AROMATASEHEMMERS
- SPC Number:
-
Dates
- Filing date:
- 15/01/2013
- Grant date:
- 02/12/2015
- EP Publication Date:
- 02/12/2015
- PCT Publication Date:
- 25/07/2013
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 26/11/2014
- EP B1 Publication Date:
- 02/12/2015
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- 15/01/2019
- Expiration date:
- 15/01/2033
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 15/01/2013
-
-
- Name:
- Novartis AG
- Address:
- Lichtstrasse 35, 4056 Basel, Switzerland (CH)
Inventor
1
- Name:
- SUTTON Paul
- Address:
- United States (US)
2
- Name:
- LOESER Eric
- Address:
- United States (US)
Priority
- Priority Number:
- 201261587280
- Priority Date:
- 17/01/2012
- Priority Country:
- United States (US)
Classification
- Main IPC Class:
-
C07D 487/04;
Annual Fees
- Annual Fee Due Date:
-
- Annual Fee Number:
-
- Expected Payer:
-
- Last Annual Fee Payment Date:
- 28/12/2017
- Last Annual Fee Paid Number:
- 6
- Last Annual Fee Paid Amount:
- 66 Euro
- Payer:
- MARKS & CLERK LLP